Papel de los biomarcadores en el cáncer urotelial

7 / 27

stroma predicts benefit to
pembrolizumab in bladder
cancer
Balar, AV et al. ESMO 2016
1L pembrolizumab in cisplatin-ineligible unresectable or metastatic urothelial
cancer: KEYNOTE-052
Vuky, J et al. ASCO 2018